======= MCL1 ======= == Gene Information == * **Official Symbol**: MCL1 * **Official Name**: MCL1 apoptosis regulator, BCL2 family member * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4170|4170]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q07820|Q07820]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MCL1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MCL1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/159552|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an anti-apoptotic protein, which is a member of the Bcl-2 family. Alternative splicing results in multiple transcript variants. The longest gene product (isoform 1) enhances cell survival by inhibiting apoptosis while the alternatively spliced shorter gene products (isoform 2 and isoform 3) promote apoptosis and are death-inducing. [provided by RefSeq, Oct 2010]. * **UniProt Summary**: N/A |Bcl-2| |positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway| |positive regulation of oxidative stress-induced neuron death| |BH3 domain binding| |Bcl-2 family protein complex| |positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway| |regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway| |positive regulation of oxidative stress-induced cell death| |positive regulation of cellular response to oxidative stress| |negative regulation of anoikis| |positive regulation of response to oxidative stress| |protein transmembrane transporter activity| |regulation of anoikis| |regulation of oxidative stress-induced neuron death| |regulation of oxidative stress-induced intrinsic apoptotic signaling pathway| |signal transduction in absence of ligand| |extrinsic apoptotic signaling pathway in absence of ligand| |negative regulation of signal transduction in absence of ligand| |negative regulation of extrinsic apoptotic signaling pathway in absence of ligand| |cell fate determination| |regulation of extrinsic apoptotic signaling pathway in absence of ligand| |positive regulation of neuron apoptotic process| |positive regulation of intrinsic apoptotic signaling pathway| |protein transmembrane transport| |regulation of oxidative stress-induced cell death| |intrinsic apoptotic signaling pathway in response to DNA damage| |regulation of cellular response to oxidative stress| |negative regulation of autophagy| |regulation of response to oxidative stress| |positive regulation of neuron death| |negative regulation of intrinsic apoptotic signaling pathway| |extrinsic apoptotic signaling pathway| |negative regulation of extrinsic apoptotic signaling pathway| |intrinsic apoptotic signaling pathway| |regulation of extrinsic apoptotic signaling pathway| |regulation of intrinsic apoptotic signaling pathway| |mitochondrial outer membrane| |positive regulation of apoptotic signaling pathway| |regulation of neuron apoptotic process| |regulation of response to DNA damage stimulus| |negative regulation of apoptotic signaling pathway| |cell fate commitment| |negative regulation of cellular catabolic process| |apoptotic signaling pathway| |negative regulation of catabolic process| |regulation of neuron death| |regulation of autophagy| |regulation of apoptotic signaling pathway| |protein heterodimerization activity| |negative regulation of intracellular signal transduction| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |cytokine-mediated signaling pathway| |positive regulation of cell death| |regulation of cellular response to stress| |cellular response to DNA damage stimulus| |regulation of cellular catabolic process| |protein homodimerization activity| |negative regulation of apoptotic process| |cellular homeostasis| |negative regulation of programmed cell death| |apoptotic process| |regulation of catabolic process| |negative regulation of cell death| |cellular response to cytokine stimulus| |positive regulation of intracellular signal transduction| |programmed cell death| |cell death| |response to cytokine| |mitochondrion| |negative regulation of signal transduction| |transmembrane transport| |negative regulation of cell communication| |negative regulation of signaling| |regulation of response to stress| |protein transport| |peptide transport| |regulation of apoptotic process| |regulation of programmed cell death| |amide transport| |establishment of protein localization| |negative regulation of response to stimulus| |homeostatic process| |positive regulation of signal transduction| |regulation of cell death| |intracellular signal transduction| |cellular response to stress| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |nitrogen compound transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|1.72| |[[:results:exp303|39°C R06 exp303]]|1.74| |[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|1.78| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|1.8| |[[:results:exp480|ETC-159 50μM R08 exp480]]|1.83| |[[:results:exp512|Olaparib 4μM R08 exp512]]|1.92| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|1.92| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|2.01| |[[:results:exp85|UM0129480 7μM R02 exp85]]|2.01| |[[:results:exp52|Ribavirin 10μM R01 exp52]]|2.02| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|2.08| |[[:results:exp218|A-395 10μM R05 exp218]]|2.12| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|2.12| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|2.12| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|2.17| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|2.17| |[[:results:exp485|GSK626616 14μM R08 exp485]]|2.23| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|2.26| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|2.42| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|2.43| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|2.46| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|2.46| |[[:results:exp528|TGF-beta1 44ng/ml R08 exp528]]|2.54| |[[:results:exp116|AICAR 240μM R03 exp116]]|2.56| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|2.57| |[[:results:exp225|Celastrol 0.12μM R05 exp225]]|2.66| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|2.67| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|2.74| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|2.74| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|2.78| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|3.46| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|4.09| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|4.44| ^Gene^Correlation^ |[[:human genes:m:march5|MARCH5]]|0.424| |[[:human genes:v:vdac2|VDAC2]]|0.421| Global Fraction of Cell Lines Where Essential: 141/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|12/28| |bone|7/26| |breast|11/33| |central nervous system|11/56| |cervix|0/4| |colorectal|3/17| |esophagus|1/13| |fibroblast|0/1| |gastric|2/16| |kidney|0/21| |liver|6/20| |lung|8/75| |lymphocyte|8/16| |ovary|2/26| |pancreas|0/24| |peripheral nervous system|3/16| |plasma cell|9/15| |prostate|1/1| |skin|3/24| |soft tissue|1/9| |thyroid|0/2| |upper aerodigestive|5/22| |urinary tract|3/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 620 * **Expression level (log2 read counts)**: 7.98 {{:chemogenomics:nalm6 dist.png?nolink |}}